“The Risks of Indiscriminate Use of Femproporex As an Appetite Inhibitor: A Review”. Research, Society and Development, vol. 10, no. 13, Oct. 2021, p. e35101321246, https://doi.org/10.33448/rsd-v10i13.21246.